Koniaris Leonidas G, Seibel Jeffrey A, Geschwind Jean-Francois, Sitzmann James V
Departments of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Hepatogastroenterology. 2003 Jan-Feb;50(49):69-72.
Administration of ethanol, whether applied directly to tissue or via an intra-arterial route, has been widely used to treat a variety of hepatic disorders, most importantly hepatocellular carcinoma. Animal studies, however, have demonstrated that intravascular hepatic ethanol therapy causes significant bile duct injury, and therefore, many centers have used intravascular ethanol applications with caution. A case of extensive bile duct injury in a 35-year-old female with a symptomatic hepatic hemangioma treated with ethanol embolization is presented. Although a seemingly rare complication, the possibility of bile duct injury should be considered prior to planned ethanol liver treatment, and a high index of suspicion should be maintained should signs of hepatic dysfunction subsequently arise.
乙醇给药,无论是直接应用于组织还是通过动脉内途径,已被广泛用于治疗各种肝脏疾病,最重要的是肝细胞癌。然而,动物研究表明,血管内肝乙醇治疗会导致严重的胆管损伤,因此,许多中心在使用血管内乙醇治疗时都很谨慎。本文介绍了一例35岁有症状的肝血管瘤女性患者,接受乙醇栓塞治疗后发生广泛胆管损伤的病例。尽管这是一种看似罕见的并发症,但在计划进行乙醇肝治疗之前应考虑胆管损伤的可能性,并且如果随后出现肝功能障碍的迹象,应保持高度的怀疑。